Please click for
HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) and
EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg)
full Prescribing Information, including BOXED WARNING.

Unsubscribe

To unsubscribe, please enter the e-mail address that you originally registered with.

HARVONI, the HARVONI logo, EPCLUSA, the EPCLUSA logo, SUPPORT PATH, the SUPPORT PATH logo, GILEAD and the GILEAD logo are trademarks of Gilead Sciences, Inc., or its related companies. All other trademarks herein are the property of their respective owners.

©2017 Gilead Sciences, Inc. All rights reserved. PTFP0729 3/17

By following this link, you are now leaving www.mysupportpath.com. The site you are entering is not controlled by Gilead Sciences, Inc., and Gilead is not responsible for its content or your use of it.